Davita Inc.
DVANYSECIK 927066HealthcareFiscal year ends Dec 31
Reports and events: 337 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2023-07-1317:16 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-23-000162 |
| 2023-06-0816:47 ET | 8-K | 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0000927066-23-000152 |
| 2023-05-0817:03 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000927066-23-000104 |
| 2023-05-0816:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-23-000102 |
| 2023-05-0118:17 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000927066-23-000096 |
| 2023-04-2516:25 ET | DEF 14A | Proxy statement | 0000927066-23-000088 |
| 2023-03-2106:22 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-23-000070 |
| 2023-02-2217:19 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000927066-23-000011 |
| 2023-02-2216:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-23-000009 |
| 2022-10-3118:02 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000927066-22-000167 |
| 2022-10-2806:33 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-22-000164 |
| 2022-10-1816:48 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0000927066-22-000160 |
| 2022-09-1317:17 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-22-000152 |
| 2022-08-0117:07 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000927066-22-000133 |
| 2022-08-0116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-22-000131 |
| 2022-06-1416:29 ET | 8-K | 5.07 Shareholder vote results | 0000927066-22-000121 |
| 2022-05-2606:45 ET | 8-K | 7.01 Regulation FD disclosure | 0000927066-22-000110 |
| 2022-05-0517:07 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000927066-22-000077 |
| 2022-05-0516:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-22-000075 |
| 2022-04-2506:16 ET | DEF 14A | Proxy statementPeriod 2022-06-09 | 0000927066-22-000061 |
| 2022-04-0818:34 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-22-000046 |
| 2022-02-1116:07 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000927066-22-000012 |
| 2022-02-1016:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-22-000006 |
| 2022-02-0917:03 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000927066-22-000002 |
| 2021-12-1717:16 ET | 8-K | 8.01 Other events | 0000927066-21-000189 |
| 2021-10-2817:04 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0000927066-21-000166 |
| 2021-10-2816:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-21-000164 |
| 2021-09-0916:48 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-21-000159 |
| 2021-08-0317:04 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0000927066-21-000136 |
| 2021-08-0316:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-21-000135 |
| 2021-06-1416:58 ET | 8-K | 5.07 Shareholder vote results | 0000927066-21-000127 |
| 2021-05-2116:38 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-21-000117 |
| 2021-04-2917:06 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0000927066-21-000074 |
| 2021-04-2916:09 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-21-000072 |
| 2021-04-2316:49 ET | DEF 14A | Proxy statementPeriod 2021-06-10 | 0001206774-21-001233 |
| 2021-03-0906:04 ET | 8-K | 7.01 Regulation FD disclosure | 0000927066-21-000032 |
| 2021-02-2616:25 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000927066-21-000022 |
| 2021-02-2518:11 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000927066-21-000019 |
| 2021-02-2408:17 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000927066-21-000016 |
| 2021-02-1216:07 ET | 10-K | Annual reportPeriod 2020-12-31 | 0000927066-21-000008 |
| 2021-02-1116:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-21-000004 |
| 2020-12-1016:48 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0000927066-20-000266 |
| 2020-11-1316:16 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0000927066-20-000219 |
| 2020-10-2917:05 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0000927066-20-000215 |
| 2020-10-2916:14 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000927066-20-000213 |
| 2020-10-0506:25 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-20-000209 |
| 2020-09-0816:27 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001193125-20-241042 |
| 2020-08-1707:22 ET | 8-K | 7.01 Regulation FD disclosure; 8.01 Other events | 0001193125-20-221701 |
| 2020-08-1117:06 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000927066-20-000177 |
| 2020-08-1121:53 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0000927066-20-000174 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Oct 29, 2026, 20:16 ET. Listed shows no prices and gives no investment advice.